NovaResp, a company dedicated to revolutionizing sleep apnea treatment with AI technology, has successfully raised $3,000,000 in funding. This significant investment will further their mission of maximizing patient comfort and adherence to CPAP therapy, addressing one of the most pressing issues in sleep apnea treatment. By leveraging cutting-edge AI solutions, NovaResp aims to enhance the effectiveness of CPAP therapy and ultimately improve the quality of life for millions of individuals suffering from sleep apnea. With this latest round of funding, NovaResp is well-positioned to continue their innovative work towards transforming the landscape of sleep apnea treatment and providing patients with more comfortable and effective solutions.












